Compare Kinder Morgan Inc (KMI) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinder Morgan Inc vs Neurocrine Biosciences Inc — how do they compare? Kinder Morgan Inc trades at $31.46 (market cap $70.10B), while Neurocrine Biosciences Inc trades at $152.18 (market cap $16.46B). The key difference: Kinder Morgan Inc is far larger — about 4.3× Neurocrine Biosciences Inc's market cap, and Kinder Morgan Inc pays a 3.75% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| KMI | NBIX | |
|---|---|---|
Market Cap | $70.10B | $16.46B |
Sector | Energy | Health |
52-Week High | $34.31 | $185.50 |
52-Week Low | $25.84 | $123.10 |
Enterprise Value | $102.15B | $16.48B |
Dividend Yield | 3.75% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
